Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Erwin

Showing results (111-120 of 154) with videos related to

Pageof 16
Sort By:
Diagnostic Microbiology and Infectious Disease|November 1, 1991
In vitro activity of RU29246. The metabolite of a new HR916 cephalosporin esterR N Jones, M E Erwin, M S Barrett, et al.
Antimicrobial Agents and Chemotherapy|September 1, 1992
Antimicrobial activities of two investigational fluoroquinolones (CI-960 and E4695) against over 100 Legionella sp. isolatesB B Gooding, M E Erwin, M S Barrett, et al.
Diagnostic Microbiology and Infectious Disease|January 8, 2000
Development of in vitro susceptibility testing methods for gemifloxacin (formerly LB20304a or SB-265805), an investigational fluoronaphthyridoneR N Jones, M E Erwin, D J Biedenbach, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|August 1, 1992
Antimicrobial activity of ten macrolide, lincosamine and streptogramin drugs tested against Legionella speciesD M Johnson, M E Erwin, M S Barrett, et al.
Diagnostic Microbiology and Infectious Disease|September 1, 1991
In vitro activity evaluations of cefdinir (FK482, CI-983, and PD134393). A novel orally administered cephalosporinB M Briggs, R N Jones, M E Erwin, et al.
Diagnostic Microbiology and Infectious Disease|September 1, 1991
Antimicrobial activity evaluations of two new quinolones, PD127391 (CI-960 and AM-1091) and PD131628M S Barrett, R N Jones, M E Erwin, et al.
Diagnostic Microbiology and Infectious Disease|December 1, 1994
Evaluation of the Etest for antimicrobial spectrum and potency determinations of anaerobes associated with bacterial vaginosis and peritonitisJ L Croco, M E Erwin, J M Jennings, et al.
Journal of Clinical Microbiology|May 15, 1999
Activity of gatifloxacin against Haemophilus influenzae and Moraxella catarrhalis, including susceptibility test development, E-test comparisons, and quality control guidelines for H. influenzaeR N Jones, D J Biedenbach, M E Erwin, et al.
Diagnostic Microbiology and Infectious Disease|February 6, 1999
The prevalence of fluoroquinolone resistance among clinically significant respiratory tract isolates of Streptococcus pneumoniae in the United States and Canada--1997 results from the SENTRY Antimicrobial Surveillance ProgramG V Doern, M A Pfaller, M E Erwin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 1, 1995
Evaluation of the Etest for determinations of antimicrobial spectrum and potency against anaerobes associated with bacterial vaginosis and peritonitisJ L Croco, M E Erwin, J M Jennings, et al.
Pageof 16

Showing results (111-120 of 154) with videos related to

Sort By:
Pageof 16
Diagnostic Microbiology and Infectious Disease|November 1, 1991
In vitro activity of RU29246. The metabolite of a new HR916 cephalosporin esterR N Jones, M E Erwin, M S Barrett, et al.
Antimicrobial Agents and Chemotherapy|September 1, 1992
Antimicrobial activities of two investigational fluoroquinolones (CI-960 and E4695) against over 100 Legionella sp. isolatesB B Gooding, M E Erwin, M S Barrett, et al.
Diagnostic Microbiology and Infectious Disease|January 8, 2000
Development of in vitro susceptibility testing methods for gemifloxacin (formerly LB20304a or SB-265805), an investigational fluoronaphthyridoneR N Jones, M E Erwin, D J Biedenbach, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|August 1, 1992
Antimicrobial activity of ten macrolide, lincosamine and streptogramin drugs tested against Legionella speciesD M Johnson, M E Erwin, M S Barrett, et al.
Diagnostic Microbiology and Infectious Disease|September 1, 1991
In vitro activity evaluations of cefdinir (FK482, CI-983, and PD134393). A novel orally administered cephalosporinB M Briggs, R N Jones, M E Erwin, et al.
Diagnostic Microbiology and Infectious Disease|September 1, 1991
Antimicrobial activity evaluations of two new quinolones, PD127391 (CI-960 and AM-1091) and PD131628M S Barrett, R N Jones, M E Erwin, et al.
Diagnostic Microbiology and Infectious Disease|December 1, 1994
Evaluation of the Etest for antimicrobial spectrum and potency determinations of anaerobes associated with bacterial vaginosis and peritonitisJ L Croco, M E Erwin, J M Jennings, et al.
Journal of Clinical Microbiology|May 15, 1999
Activity of gatifloxacin against Haemophilus influenzae and Moraxella catarrhalis, including susceptibility test development, E-test comparisons, and quality control guidelines for H. influenzaeR N Jones, D J Biedenbach, M E Erwin, et al.
Diagnostic Microbiology and Infectious Disease|February 6, 1999
The prevalence of fluoroquinolone resistance among clinically significant respiratory tract isolates of Streptococcus pneumoniae in the United States and Canada--1997 results from the SENTRY Antimicrobial Surveillance ProgramG V Doern, M A Pfaller, M E Erwin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 1, 1995
Evaluation of the Etest for determinations of antimicrobial spectrum and potency against anaerobes associated with bacterial vaginosis and peritonitisJ L Croco, M E Erwin, J M Jennings, et al.
Pageof 16